REFERENCES
Abe T, Amaike Y, Shizu R, Takahashi M, Kano M, Hosaka T, et al.(2018). Role of YAP Activation in Nuclear Receptor CAR-Mediated Proliferation of Mouse Hepatocytes. Toxicol Sci 165: 408-419.
Bhushan B, Stoops JW, Mars WM, Orr A, Bowen WC, Paranjpe S, et al. (2019). TCPOBOP-Induced Hepatomegaly and Hepatocyte Proliferation are Attenuated by Combined Disruption of MET and EGFR Signaling. Hepatology 69: 1702-1718.
Blanco-Bose WE, Murphy MJ, Ehninger A, Offner S, Dubey C, Huang W, et al. (2008). C-Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia. Hepatology 48: 1302-1311.
Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, et al. (2007). YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17: 2054-2060.
Chai X, Zeng S, & Xie W (2013). Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond. Expert Opin Drug Metab Toxicol 9: 253-266.
Costa RH, Kalinchenko VV, Tan YJ, & Wang IC (2005). The CAR nuclear receptor and hepatocyte proliferation. Hepatology 42:1004-1008.
Dash AK, Yende AS, Kumar S, Singh SK, Kotiya D, Rana M, et al.(2014). The Constitutive Androstane Receptor (CAR): a nuclear receptor in health and disease. J Endocrinol&Reprod 18: 59-74.
Deng YZ, Chen PP, Wang Y, Yin D, Koeffler HP, Li BJ, et al.(2007). Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling. J Biol Chem 282:36571-36581.
Eloranta JJ, & Kullak-Ublick GA (2005). Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 433: 397-412.
Fan F, He Z, Kong L-L, Chen Q, Yuan Q, Zhang S, et al. (2016). Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Sci Transl Med 8.
Ganzenberg K, Singh Y, & Braeuning A (2013). The time point of beta-catenin knockout in hepatocytes determines their response to xenobiotic activation of the constitutive androstane receptor. Toxicology 308: 113-121.
Geng Y, Whoriskey W, Park MY, Bronson RT, Medema RH, Li TS, et al. (1999). Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 97: 767-777.
Jiang Y, Feng D, Ma X, Fan S, Gao Y, Fu K, et al. (2019). Pregnane X Receptor Regulates Liver Size and Liver Cell Fate by Yes-Associated Protein Activation in Mice. Hepatology 69:343-358.
Jungermann K, & Katz N (1989). Functional specialization of different hepatocyte populations. Physiol Rev 69: 708-764.
Kachaylo EM, Pustylnyak VO, Lyakhovich VV, & Gulyaeva LF (2011). Constitutive androstane receptor (CAR) is a xenosensor and target for therapy. Biochemistry (Mosc) 76: 1087-1097.
Kodama S, & Negishi M (2006). Phenobarbital confers its diverse effects by activating the orphan nuclear receptor car. Drug Metab Rev 38: 75-87.
Kojic S, Nestorovic A, Rakicevic L, Belgrano A, Stankovic M, Divac A, et al. (2010). A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein. Arch Biochem Biophys 502: 60-67.
Konno Y, Negishi M, & Kodama S (2008). The roles of nuclear receptors CAR and PXR in hepatic energy metabolism. Drug Metab Pharmacok 23: 8-13.
Kowalik MA, Saliba C, Pibiri M, Perra A, Ledda-Columbano GM, Sarotto I, et al. (2011). Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice. Hepatology 53: 2086-2096.
Labbe E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, et al. (2007). Transcriptional cooperation between the transforming growth factor-beta and wnt pathways in mammary and intestinal tumorigenesis. Cancer Res 67: 75-84.
Li ZQ, Ding W, Sun SJ, Li J, Pan J, Zhao C, et al. (2012). Cyr61/CCN1 Is Regulated by Wnt/beta-Catenin Signaling and Plays an Important Role in the Progression of Hepatocellular Carcinoma. Plos One 7.
Luo Q, Kang Q, Si WK, Jiang W, Park JK, Peng Y, et al. (2004). Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279: 55958-55968.
Mao SA, Glorioso JM, & Nyberg SL (2014). Liver regeneration. Transl Res 163: 352-362.
Min G, Kim H, Bae Y, Petz L, & Kemper JK (2002). Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators. J Biol Chem 277: 34626-34633.
Oh SH, Swiderska-Syn M, Jewell ML, Premont RT, & Diehl AM (2018). Liver regeneration requires Yap1-TGFbeta-dependent epithelial-mesenchymal transition in hepatocytes. J Hepatol 69: 359-367.
Patel SH, Camargo FD, & Yimlamai D (2017). Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis. Gastroenterology 152: 533-545.
Qatanani M, & Moore DD (2005). CAR, the continuously advancing receptor, in drug metabolism and disease. Curr Drug Metab 6:329-339.
Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, et al. (2010). Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci U S A 107:1431-1436.
Sugatani J, Yamakawa K, Yoshinari K, Machida T, Takagi H, Mori M, et al. (2002). Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Bioph Res Co 292: 492-497.
Tschuor C, Kachaylo E, Limani P, Raptis DA, Linecker M, Tian Y, et al. (2016). Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue loss. J Hepatol 65: 66-74.
Wei P, Zhang J, Egan-Hafley M, Liang SG, & Moore DD (2000). The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407: 920-923.
Willson TM, & Kliewer SA (2002). PXR, CAR and drug metabolism. Nat Rev Drug Discov 1: 259-266.